Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

86 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Within-Trial Evaluation of Medical Resources, Costs, and Quality of Life Among Patients With Type 2 Diabetes Participating in the Exenatide Study of Cardiovascular Event Lowering (EXSCEL).
Reed SD, Li Y, Dakin HA, Becker F, Leal J, Gustavson SM, Kartman B, Wittbrodt E, Mentz RJ, Pagidipati NJ, Bethel MA, Gray AM, Holman RR, Hernandez AF; EXSCEL Study Group. Reed SD, et al. Among authors: bethel ma. Diabetes Care. 2020 Feb;43(2):374-381. doi: 10.2337/dc19-0950. Epub 2019 Dec 5. Diabetes Care. 2020. PMID: 31806653 Free PMC article. Clinical Trial.
Therapy of type 2 diabetes, cardiovascular death, and the UGDP.
Feinglos MN, Bethel MA. Feinglos MN, et al. Among authors: bethel ma. Am Heart J. 1999 Nov;138(5 Pt 1):S346-52. doi: 10.1016/s0002-8703(99)70034-7. Am Heart J. 1999. PMID: 10539796 Clinical Trial. No abstract available.
Diabetes and early postoperative outcomes following lumbar fusion.
Browne JA, Cook C, Pietrobon R, Bethel MA, Richardson WJ. Browne JA, et al. Among authors: bethel ma. Spine (Phila Pa 1976). 2007 Sep 15;32(20):2214-9. doi: 10.1097/BRS.0b013e31814b1bc0. Spine (Phila Pa 1976). 2007. PMID: 17873813
Rationale, design, and organization of a randomized, controlled Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS) in patients with type 2 diabetes and established cardiovascular disease.
Green JB, Bethel MA, Paul SK, Ring A, Kaufman KD, Shapiro DR, Califf RM, Holman RR. Green JB, et al. Among authors: bethel ma. Am Heart J. 2013 Dec;166(6):983-989.e7. doi: 10.1016/j.ahj.2013.09.003. Epub 2013 Oct 23. Am Heart J. 2013. PMID: 24268212 Clinical Trial.
Role of diuretics, β blockers, and statins in increasing the risk of diabetes in patients with impaired glucose tolerance: reanalysis of data from the NAVIGATOR study.
Shen L, Shah BR, Reyes EM, Thomas L, Wojdyla D, Diem P, Leiter LA, Charbonnel B, Mareev V, Horton ES, Haffner SM, Soska V, Holman R, Bethel MA, Schaper F, Sun JL, McMurray JJ, Califf RM, Krum H. Shen L, et al. Among authors: bethel ma. BMJ. 2013 Dec 9;347:f6745. doi: 10.1136/bmj.f6745. BMJ. 2013. PMID: 24322398 Free PMC article.
Association between change in daily ambulatory activity and cardiovascular events in people with impaired glucose tolerance (NAVIGATOR trial): a cohort analysis.
Yates T, Haffner SM, Schulte PJ, Thomas L, Huffman KM, Bales CW, Califf RM, Holman RR, McMurray JJ, Bethel MA, Tuomilehto J, Davies MJ, Kraus WE. Yates T, et al. Among authors: bethel ma. Lancet. 2014 Mar 22;383(9922):1059-66. doi: 10.1016/S0140-6736(13)62061-9. Epub 2013 Dec 20. Lancet. 2014. PMID: 24361242 Clinical Trial.
86 results